Oslo Cancer Cluster

What a day! The Kristian Berg Symposium, «Innovative Approaches for Cancer Targeting», at the Institute for Cancer Research, Oslo universitetssykehus turned out to be very successful with >150 attendes. Santi Nonell learned us about the importance of light from a evolutionary perspective. Tayyaba Hasan (Visudyne) and John Lambert (Kadcyla) both behind world-wide approved drugs, gave wonderful talks and stressed the importance of research and innovation. And much more by: Anne Simonsen #Endocytosis & #Autophagy, Kristine Young-Halvorsen from Photocure, Anders Høgset from PCI Biotech Holding ASA, Ole-Jacob Norum #Sarcoma from Oslo universitetssykehus, Jonas Einarsson from RADFORSK, Anette Weyergang from Oslo universitetssykehus & RAB Diagnostics and finally Kristian Berg with 40 years in one slide/«20 min» #CancerResearch #Photomedicine #Innovation Kjetil Tasken Eirik Malinen Big Thank you to Oslo Cancer Cluster for co-arrangement.

Thank you Thermo Fisher Scientific and Tuva Holt Hereng for arranging the highly interesting Cell Therapy Innovation Symposium 2024. 🥼 We enjoyed to learn more about how to develop companies and practical aspects of cell therapy manufacturing. 🏗️ We’re happy to have Thermo Fisher Scientific as a valued member of our cluster, and a key player in the current expansion of Oslo Cancer Cluster Innovation Park. The company has signed a lease for nearly four floors (two lab floors and two office floors) compromising almost 75 per cent of the entire fourth tower being constructed on the western side of the premises. 🔬 This is an important investment in the Norwegian health industry and in getting new innovations to cancer patients. 🧫 Thermo Fisher Scientific is also a partner for The CellFit Project, funded by Norges forskningsråd, and led by Oslo universitetssykehus with partners Oslo Cancer Cluster and SINTEF. The main aim of the CellFit project is to improve efficacy of cell therapies by optimising T-cell production to obtain T-cells with more stem-like properties. ➡️ Find out more: www.cellfitproject.com

We are starting a new project with HealthCatalyst and Innovation Norway! The aim is to assist Norwegian health companies to enter the German market. 🇩🇪 This is part of the Norwegian government's health export strategy. Germany is a key market for Norwegian health companies. We are excited! 😃

It's inspiring to participate in the symposium Innovative Approaches to Cancer Targeting at the Institute for Cancer Research today. The research in photodynamic therapy, photochemical internalisation and antibody drug conjugates from Kristian Berg 's group has not only become renowned globally, but also resulted in cancer innovations and the companies PCI Biotech Holding ASA, Photocure and RAB Diagnostics. This is research making a difference for patients and creating value for society. Thank you for giving us a glimpse into what photobiology can achieve!

Virkelig spennende og gode nyheter innen #radiofarmasifeltet og utviklingen av morgendagens kreftbehandlinger. Vårt porteføljeselskap ARTBIO inngår leveringsavtale på thorium fra Thor Medical ASA sitt pilotproduksjonsanlegg på Herøya. For en vinn - vinn - vinn: ⭐️ARTBIO får forsyningssikkerhet for produksjon av bly-isotopen de bruker i sine legemiddelkandidater ⭐️Thor Medical får validert produksjonsteknologien sin ⭐️ Det norske økosystemet innen radiofarmasi blir ytterligere styrket. Vi har lange tradisjoner innen feltet og har masse kompetanse og et tett nettverk fra forskning til produksjon ⭐️ Kreftpasientene får potensielt ny og bedre behandling ⭐️ Norsk helsenæring vokser Radiofarmasi er ett av fagfeltene vi ønsker å satse på i Oslo Science Hub der vi tror vertskapsattraktiviteten opp mot internasjonal industri er enormt stor. Jonas Einarsson Emanuele Ostuni Anders Tuv Thomas London Alf Bjørseth Leif Rune Skymoen Legemiddelindustrien (LMI) NHO Viken Oslo Vegard Einan Mariette Christophersen Bøe Kjetil Tasken Asta Juzeniene Bayer Frode Nakkim Norsk medisinsk syklotronsenter AS Thor Audun Saga

Important new collaboration in radiopharmacy between ARTBIO and Thor Medical ASA. Well done! Read the news here: https://lnkd.in/dJftnpPe?

It's almost that time of year again! Save the date for the December Gathering at Oslo Cancer Cluster on December 5th! It is always a great networking event, meet fellow members, and listen to introductions and updates from across the ecosystem. Register today to reserve your place; https://lnkd.in/dEiF7b8d

Da har vi endelig begynt å kle inn vårt nye bygg i hjertet av Campus Radiumhospitalet. Lamell 4 skal oppkalles etter John Ugelstad og romme blandt annet ThermoFisher, Aktiv mot Kreft, celleterapi og avdelinger fra Radiumhospitalet. Et veldig miljøvennlig bygg med trefasade. Ansatte, pasienter og pårørende vil sikkert sette pris på restaurant og kafeteriatilbud også.

"Utvikle økosystem og skape verskapsattraktivitet for riktige investorer" Thomas London Oslo Science hub Oslo Cancer Cluster Incubator poengterer hvordan kapitalmiljøer er en viktig katalysator for helsenæring i Norge DNB Health2B Norway Norway Health Tech Oslo Cancer Cluster The Life Science Cluster Norwegian Smart Care Cluster Innovation Norway

"Verdens største produsent av legemidler Thermo Fisher Scientific legger to forskningssenter til Oslo. Thomas London bygger opp Oslo Science Hub. Sammen investerer de flere milliarder i forskningsinfrastruktur i Oslo. Hvordan kan vi som land gå inn politisk og matcha de private aktørenes investeringer med offentlig finansiering?" Ketil F. Widerberg fra Oslo Cancer Cluster utfordrer Solveig Østby Vitanza (Arbeiderpartiet) og Sveinung Stensland (Høyre) i politisk samtale på DNB Nxt Healthcare-konferansen i dag. Takk til DNB og Norway Health Tech for veldig bra og, ikke minst, viktig konferanse i dag.